The DOI matches its Crossref record; 496 of the 496 references it cites were found in a registry or an index.
Toxicity of amphetamines: an update
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lachman, H. M., Papolos, D. F., Saito, T., Yu, Y.-M., Szumlanski, C. L., & Weinshilboum, R. M. (1996) · Pharmacogenetics · doi:10.1097/00008571-199606000-00007 · Cited by 1,788 · cited 4×
“4-hydroxy-3-methoxybenzoic acid 4-hydroxy-3-methoxyhippuric acid V VI V VI VI VI III III III III III III V CYP2D6 CYP2D6 CYP2D6 CYP2D6 CYP2D6 CYP2D6 CYP2D6 CYP2D6 CYP2C COMT”
BackgroundInfluentialRole of Quinones in Toxicology
Bolton, J. L., Trush, M. A., Penning, T. M., Dryhurst, G., & Monks, T. J. (2000) · Chemical Research in Toxicology · doi:10.1021/tx9902082 · Cited by 1,703
A double‐blind, placebo‐controlled trial
Pinals, R. S., Kaplan, S. B., Lawson, J. G., & Hepburn, B. (1986) · Arthritis & Rheumatism · doi:10.1002/art.1780291202 · Cited by 1,355
The Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”)
Green, A. R., Mechan, A. O., Elliott, J. M., O’Shea, E., & Colado, M. I. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.3.3 · Cited by 1,272
Mechanisms of neurotransmitter release by amphetamines: A review
Sulzer, D., Sonders, M. S., Poulsen, N. W., & Galli, A. (2005) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2005.04.003 · Cited by 1,209
Lotta, T., Vidgren, J., Tilgmann, C., Ulmanen, I., Melen, K., Julkunen, I., & Taskinen, J. (1995) · Biochemistry · doi:10.1021/bi00013a008 · Cited by 1,167
Rothman, R. B., Baumann, M. H., Dersch, C. M., Romero, D. V., Rice, K. C., Carroll, F. I., & Partilla, J. S. (2001) · Synapse · doi:10.1002/1098-2396(20010101)39:1<32::aid-syn5>3.0.co;2-3 · Cited by 938
Mattay, V. S., Goldberg, T. E., Fera, F., Hariri, A. R., Tessitore, A., Egan, M. F., Kolachana, B., Callicott, J. H., & Weinberger, D. R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0931309100 · Cited by 893
A review of the clinical pharmacology of methamphetamine
Cruickshank, C. C., & Dyer, K. R. (2009) · Addiction · doi:10.1111/j.1360-0443.2009.02564.x · Cited by 769
Structural Abnormalities in the Brains of Human Subjects Who Use Methamphetamine
Thompson, P. M., Hayashi, K. M., Simon, S. L., Geaga, J. A., Hong, M. S., Sui, Y., Lee, J. Y., Toga, A. W., Ling, W., & London, E. D. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.0713-04.2004 · Cited by 760
The pharmacology and toxicology of "ecstasy" (MDMA) and related drugs.
Kalant, H. (2001) · Europe PMC (PubMed Central) · Cited by 743
Toxicity and deaths from 3,4-methylenedioxymethamphetamine ("ecstasy")
Henry, J. A., Jeffreys, K. J., & Dawling, S. (1992) · The Lancet · doi:10.1016/0140-6736(92)91469-o · Cited by 729
Striatal dopamine nerve terminal markers in human, chronic methamphetamine users
Wilson, J. M., Kalasinsky, K. S., Levey, A. I., Bergeron, C., Reiber, G., Anthony, R. M., Schmunk, G. A., Shannak, K., Haycock, J. W., & Kish, S. J. (1996) · Nature Medicine · doi:10.1038/nm0696-699 · Cited by 718
Sulzer, D., Chen, T., Lau, Y., Kristensen, H., Rayport, S., & Ewing, A. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-05-04102.1995 · Cited by 688
McCann, U., Szabo, Z., Scheffel, U., Dannals, R., & Ricaurte, G. (1998) · The Lancet · doi:10.1016/s0140-6736(98)04329-3 · Cited by 660
ΔΨ m ‐Dependent and ‐independent production of reactive oxygen species by rat brain mitochondria
Votyakova, T. V., & Reynolds, I. J. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00548.x · Cited by 601
Methamphetamine toxicity and messengers of death
Krasnova, I. N., & Cadet, J. L. (2009) · Brain Research Reviews · doi:10.1016/j.brainresrev.2009.03.002 · Cited by 589
Weinshilboum, R. M., Otterness, D. M., & Szumlanski, C. L. (1999) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.39.1.19 · Cited by 549
O'Hearn, E., Battaglia, G., De Souza, E., Kuhar, M., & Molliver, M. (1988) · The Journal of Neuroscience · doi:10.1523/jneurosci.08-08-02788.1988 · Cited by 542
Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine.
Schmidt, C. J. (1987) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22673-8 · Cited by 529
Davidson, C., Gow, A. J., Lee, T. H., & Ellinwood, E. H. (2001) · Brain Research Reviews · doi:10.1016/s0165-0173(01)00054-6 · Cited by 521
Benowitz, N. (2008) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2008.3 · Cited by 517
Glutathione metabolism and its role in hepatotoxicity
DeLeve, L. D., & Kaplowitz, N. (1991) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(91)90029-l · Cited by 492
Regulation of Cytochromes P450 During Inflammation and Infection
Morgan, E. T. (1997) · Drug Metabolism Reviews · doi:10.3109/03602539709002246 · Cited by 488
Dopamine nerve terminal degeneration produced by high doses of methylamphetamine in the rat brain
Ricaurte, G. A., Guillery, R. W., Seiden, L. S., Schuster, C. R., & Moore, R. Y. (1982) · Brain Research · doi:10.1016/0006-8993(82)90198-6 · Cited by 479
Excitotoxic mechanisms and the role of astrocytic glutamate transporters in traumatic brain injury
Yi, J.-H., & Hazell, A. S. (2006) · Neurochemistry International · doi:10.1016/j.neuint.2005.12.001 · Cited by 479
The pharmacology of psilocybin
Passie, T., Seifert, J., Schneider, U., & Emrich, H. M. (2002) · Addiction Biology · doi:10.1080/1355621021000005937 · Cited by 465 · cited 1×
“The consumption of ‘‘Magic’’ mushrooms containing psilocybin/psilocin along with amphetamines has a great potential for the establishment of PD interactions, since psilocybin/psilocin have sympathomimetic pro-serotonergic and pro-dopaminergic effects (Passie et al. 2002).”
BackgroundBattaglia, G., Yeh, S. Y., O'Hearn, E., Molliver, M. E., Kuhar, M. J., & De Souza, E. B. (1987) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)39191-3 · Cited by 458
Commins, D. L., Vosmer, G., Virus, R. M., Woolverton, W. L., Schuster, C. R., & Seiden, L. S. (1987) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-5347(25)00317-9 · Cited by 453
Human Pharmacology of MDMA: Pharmacokinetics, Metabolism, and Disposition
de la Torre, R., Farré, M., Roset, P. N., Pizarro, N., Abanades, S., Segura, M., Segura, J., & Camí, J. (2004) · Therapeutic Drug Monitoring · doi:10.1097/00007691-200404000-00009 · Cited by 444
The need for speed: an update on methamphetamine addiction
Barr, A. M., Panenka, W. J., MacEwan, G. W., Thornton, A. E., Lang, D. J., Honer, W. G., & Lecomte, T. (2006) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0635 · Cited by 434
Johansson, I., Oscarson, M., Yue, Q. Y., Bertilsson, L., Sjöqvist, F., & Ingelman-Sundberg, M. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09721-4 · Cited by 430
Sotaniemi, E. A., Arranto, A. J., Pelkonen, O., & Pasanen, M. (1997) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(97)90166-1 · Cited by 415
Recreational MDMA use in Sydney: a profile of ‘Ecstasy’ users and their experiences with the drug
SOLOWIJ, N., HALL, W., & LEE, N. (1992) · British Journal of Addiction · doi:10.1111/j.1360-0443.1992.tb02003.x · Cited by 413
Non‐linear pharmacokinetics of MDMA (‘ecstasy’) in humans
De La Torre, R., Farré, M., Ortuño, J., Mas, M., Brenneisen, R., Roset, P. N., Segura, J., & Camí, J. (2000) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2000.00121.x · Cited by 401
Ramamoorthy, S., & Blakely, R. D. (1999) · Science · doi:10.1126/science.285.5428.763 · Cited by 392
PARKINSON, A. (2004) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2004.01.010 · Cited by 386
Spencer, J. P. E., Jenner, P., Daniel, S. E., Lees, A. J., Marsden, D. C., & Halliwell, B. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.71052112.x · Cited by 373 · cited 1×
“These metabolites, formed in liver cells, can reach the heart, the kidney, the brain, and other organs via the circulation and produce their toxic effects, mainly due to the auto-oxidation of the catecholic groups into reactive o-quinones (Macedo et al. 2007; Spencer et al. 1998).”
BackgroundHallucinogenic Amphetamine Selectively Destroys Brain Serotonin Nerve Terminals
Ricaurte, G., Bryan, G., Strauss, L., Seiden, L., & Schuster, C. (1985) · Science · doi:10.1126/science.4023719 · Cited by 367
Mas, M., Farré, M., de la Torre, R., Roset, P. N., Segura, J. O., & Camí, J. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)34877-3 · Cited by 362
Gender differences in the subjective effects of MDMA
Liechti, M. E., Gamma, A., & Vollenweider, F. X. (2001) · Psychopharmacology · doi:10.1007/s002130000648 · Cited by 360
Bagley, W. H., Yang, H., & Shah, K. H. (2007) · Internal and Emergency Medicine · doi:10.1007/s11739-007-0060-8 · Cited by 358
Nash, J. F., & Yamamoto, B. K. (1992) · Brain Research · doi:10.1016/0006-8993(92)90713-j · Cited by 354
Malberg, J. E., & Seiden, L. S. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-13-05086.1998 · Cited by 344
Human psychopharmacology of Ecstasy (MDMA): a review of 15 years of empirical research
Parrott, A. C. (2001) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.351 · Cited by 344
Ecstasy (MDMA) effects upon mood and cognition: before, during and after a Saturday night dance
Parrott, A. C., & Lasky, J. (1998) · Psychopharmacology · doi:10.1007/s002130050714 · Cited by 340
Hatzidimitriou, G., McCann, U. D., & Ricaurte, G. A. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-12-05096.1999 · Cited by 339
McCann, U. D., Ridenour, A., Shaham, Y., & Ricaurte, G. A. (1994) · Neuropsychopharmacology · doi:10.1038/npp.1994.15 · Cited by 332
Dykens, J. A., Stern, A., & Trenkner, E. (1987) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1987.tb10014.x · Cited by 329
Methamphetamine and cardiovascular pathology: a review of the evidence
Kaye, S., McKetin, R., Duflou, J., & Darke, S. (2007) · Addiction · doi:10.1111/j.1360-0443.2007.01874.x · Cited by 319
Ellison, G., Eison, M. S., Huberman, H. S., & Daniel, F. (1978) · Science · doi:10.1126/science.26975 · Cited by 312
Long-term methamphetamine induced changes in brain catecholamines in tolerant rhesus monkeys
Seiden, L. S., Fischman, M. W., & Schuster, C. R. (1976) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(76)90030-2 · Cited by 307
Busby, W. F., Ackermann, J. M., & Crespi, C. L. (1999) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15284-1 · Cited by 307
Testing for drugs of abuse in saliva and sweat
Kidwell, D. A., Holland, J. C., & Athanaselis, S. (1998) · Journal of Chromatography B: Biomedical Sciences and Applications · doi:10.1016/s0378-4347(97)00572-0 · Cited by 300
McCann, U. D., Mertl, M., Eligulashvili, V., & Ricaurte, G. A. (1999) · Psychopharmacology · doi:10.1007/s002130050967 · Cited by 300
Schmidt, C. J., Levin, J. A., & Lovenberg, W. (1987) · Biochemical Pharmacology · doi:10.1016/0006-2952(87)90729-5 · Cited by 297
Hall, A. P., & Henry, J. A. (2006) · British Journal of Anaesthesia · doi:10.1093/bja/ael078 · Cited by 294
Molecular and Cellular Mechanisms of Ecstasy-Induced Neurotoxicity: An Overview
Capela, J. P., Carmo, H., Remião, F., Bastos, M. L., Meisel, A., & Carvalho, F. (2009) · Molecular Neurobiology · doi:10.1007/s12035-009-8064-1 · Cited by 290
Self-citationHijazi, Y., & Boulieu, R. (2002) · Drug Metabolism and Disposition · doi:10.1124/dmd.30.7.853 · Cited by 287
The Effects of Methamphetamine on the Production of Free Radicals and Oxidative Stress
Yamamoto, B. K., & Zhu, W. (1998) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37769-9 · Cited by 281
Amphetamine toxicities: Classical and emerging mechanisms
Yamamoto, B. K., Moszczynska, A., & Gudelsky, G. A. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05141.x · Cited by 279
Jayanthi, S., Deng, X., H. Noailles, P., Ladenheim, B., & Lud Cadet, J. (2004) · The FASEB Journal · doi:10.1096/fj.03-0295com · Cited by 278
Winstock, A. R., Griffiths, P., & Stewart, D. (2001) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(00)00215-5 · Cited by 276
Pathology of deaths associated with "ecstasy" and "eve" misuse.
Milroy, C. M., Clark, J. C., & Forrest, A. R. (1996) · Journal of Clinical Pathology · doi:10.1136/jcp.49.2.149 · Cited by 270
Fischer, C., Hatzidimitriou, G., Wlos, J., Katz, J., & Ricaurte, G. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-08-05476.1995 · Cited by 268
Fumagalli, F., Gainetdinov, R. R., Valenzano, K. J., & Caron, M. G. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-13-04861.1998 · Cited by 266
Biochemical and toxicological properties of the oxidation products of catecholamines
Bindoli, A., Rigobello, M. P., & Deeble, D. J. (1992) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(92)90182-g · Cited by 264
Cook, C. E., Jeffcoat, A. R., Hill, J. M., Pugh, D. E., Patetta, P. K., Sadler, B. M., White, W. R., & Perez-Reyes, M. (1993) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)07478-1 · Cited by 263
Metabolism of [14C]methamphetamine in man, the guinea pig and the rat
Caldwell, J., Dring, L. G., & Williams, R. T. (1972) · Biochemical Journal · doi:10.1042/bj1290011 · Cited by 260
Miller, D. B., & O'Callaghan, J. P. (1994) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22434-x · Cited by 259
Schepers, R. J. F., Oyler, J. M., Joseph, R. E., Cone, E. J., Moolchan, E. T., & Huestis, M. A. (2003) · Clinical Chemistry · doi:10.1373/49.1.121 · Cited by 259
Ephedra in perspective – a current review
Abourashed, E. A., El‐Alfy, A. T., Khan, I. A., & Walker, L. (2003) · Phytotherapy Research · doi:10.1002/ptr.1337 · Cited by 258
Neurotoxicity of MDMA and Related Compounds: Anatomic Studiesa
MOLLIVER, M. E., BERGER, U. V., MAMOUNAS, L. A., MOLLIVER, D. C., O'HEARN, E., & WILSON, M. A. (1990) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1990.tb16916.x · Cited by 252
Gudelsky, G. A., & Nash, J. F. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.66010243.x · Cited by 251
Liechti, M. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00148-7 · Cited by 248
Liechti, M. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00126-3 · Cited by 245
Catecholamine-Induced Cardiomyopathy
Kassim, T. A., Clarke, D. D., Mai, V. Q., Clyde, P. W., & Shakir, K. M. M. (2008) · Endocrine Practice · doi:10.4158/ep.14.9.1137 · Cited by 245
Amphetamine induces dopamine efflux through a dopamine transporter channel
Kahlig, K. M., Binda, F., Khoshbouei, H., Blakely, R. D., McMahon, D. G., Javitch, J. A., & Galli, A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407737102 · Cited by 239
Tucker, G. T., Lennard, M. S., Ellis, S. W., Woods, H. F., Cho, A. K., Lin, L. Y., Hiratsuka, A., Schmitz, D. A., & Chu, T. Y. Y. (1994) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)90386-7 · Cited by 236
Kraemer, T., & Maurer, H. H. (2002) · Therapeutic Drug Monitoring · doi:10.1097/00007691-200204000-00009 · Cited by 233
Bowyer, J. F., Tank, A. W., Newport, G. D., Slikker, W., Ali, S. F., & Holson, R. R. (1992) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)11370-0 · Cited by 233
The Background and Chemistry of MDMA
Shulgin, A. T. (1986) · Journal of Psychoactive Drugs · doi:10.1080/02791072.1986.10472361 · Cited by 233
Molecular Bases of Methamphetamine-Induced Neurodegeneration
Cadet, J. L., & Krasnova, I. N. (2009) · International Review of Neurobiology · doi:10.1016/s0074-7742(09)88005-7 · Cited by 228
Schmitz, Y., Lee, C. J., Schmauss, C., Gonon, F., & Sulzer, D. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-16-05916.2001 · Cited by 227
Induction of CYP2D6 in pregnancy*
Wadelius, M., Darj, E., Frenne, G., & Rane, A. (1997) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(97)90118-1 · Cited by 226
Mechan, A. O., Esteban, B., O'Shea, E., Elliott, J. M., Colado, M. I., & Green, A. R. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704442 · Cited by 221
Effects of 3,4-methylenedioxymethamphetamine on autonomic thermoregulatory responses of the rat
Gordon, C. J., Watkinson, W. P., O'Callaghan, J. P., & Miller, D. B. (1991) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(91)90288-d · Cited by 220
Flanagan, S. W., Moseley, P. L., & Buettner, G. R. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00779-0 · Cited by 217
MDMA (`ecstasy') consumption in the context of polydrug abuse: a report on 150 patients
Schifano, F., Di Furia, L., Forza, G., Minicuci, N., & Bricolo, R. (1998) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(98)00051-9 · Cited by 216
Ricaurte, G. A., Seiden, L. S., & Schuster, C. R. (1984) · Brain Research · doi:10.1016/0006-8993(84)91221-6 · Cited by 212
Berger, U. V., Gu, X. F., & Azmitia, E. C. (1992) · European Journal of Pharmacology · doi:10.1016/0014-2999(92)90023-w · Cited by 210
Ecstasy and the dance of death.
Henry, J. A. (1992) · BMJ · doi:10.1136/bmj.305.6844.5 · Cited by 209
Toxicokinetics and analytical toxicology of amphetamine-derived designer drugs (‘Ecstasy’)
Maurer, H. H., Bickeboeller-Friedrich, J., Kraemer, T., & Peters, F. T. (2000) · Toxicology Letters · doi:10.1016/s0378-4274(99)00207-6 · Cited by 206
Long-term effects of chronic methamphetamine administration in rhesus monkeys
Woolverton, W. L., Ricaurte, G. A., Forno, L. S., & Seiden, L. S. (1989) · Brain Research · doi:10.1016/0006-8993(89)91279-1 · Cited by 205
The Association of Methamphetamine Use and Cardiomyopathy in Young Patients
Yeo, K.-K., Wijetunga, M., Ito, H., Efird, J. T., Tay, K., Seto, T. B., Alimineti, K., Kimata, C., & Schatz, I. J. (2007) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.01.024 · Cited by 204
McCann, U. D., Szabo, Z., Seckin, E., Rosenblatt, P., Mathews, W. B., Ravert, H. T., Dannals, R. F., & Ricaurte, G. A. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300736 · Cited by 204
'Eve' and 'Ecstasy': A Report of Five Deaths Associated With the Use of MDEA and MDMA
Dowling, G. P. (1987) · JAMA · doi:10.1001/jama.1987.03390120077027 · Cited by 204
Alteration of drug biotransformation and elimination during infection and inflammation
Renton, K. W. (2001) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(01)00165-6 · Cited by 203
Methylenedioxymethamphetamine: A potentially neurotoxic amphetamine analogue
Schmidt, C. J., Wu, L., & Lovenberg, W. (1986) · European Journal of Pharmacology · doi:10.1016/0014-2999(86)90140-8 · Cited by 202
Pathogenesis and treatment of renal dysfunction in rhabdomyolysis
Korantzopoulos, P., Galaris, D., & Papaioannides, D. (2002) · Intensive Care Medicine · doi:10.1007/s00134-002-1356-9 · Cited by 199
Deng, X., Wang, Y., Chou, J., & Cadet, J. L. (2001) · Molecular Brain Research · doi:10.1016/s0169-328x(01)00184-x · Cited by 199
Ketamine: From Medicine to Misuse
Wolff, K., & Winstock, A. R. (2006) · CNS Drugs · doi:10.2165/00023210-200620030-00003 · Cited by 199
Hiramatsu, M., Kumagai, Y., Unger, S. E., & Cho, A. K. (1990) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12653-0 · Cited by 198
Kreth, K.-P., Kovar, K.-A., Schwab, M., & Zanger, U. M. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00284-7 · Cited by 198
High Dose Pimozide Does Not Block Amphetamine-Induced Euphoria in Normal Volunteers
Brauer, L. (1997) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(96)00240-7 · Cited by 194
Microglial activation is a pharmacologically specific marker for the neurotoxic amphetamines
Thomas, D. M., Dowgiert, J., Geddes, T. J., Francescutti-Verbeem, D., Liu, X., & Kuhn, D. M. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.06.065 · Cited by 193
Altered states: the clinical effects of Ecstasy
Cole, J. C., & Sumnall, H. R. (2003) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(03)00003-2 · Cited by 192
Hernández-López, C., Farré, M., Roset, P. N., Menoyo, E., Pizarro, N., Ortuño, J., Torrens, M., Camı́, J., & de la Torre, R. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.300.1.236 · Cited by 191
Inhibition of monoamine oxidase by amphetamine and related compounds
Mantle, T. J., Tipton, K. F., & Garrett, N. J. (1976) · Biochemical Pharmacology · doi:10.1016/0006-2952(76)90432-9 · Cited by 191
Raimundo, S., Fischer, J., Eichelbaum, M., Griese, E.-U., Schwab, M., & Zanger, U. M. (2000) · Pharmacogenetics · doi:10.1097/00008571-200010000-00001 · Cited by 189
Causes and consequences of methamphetamine and MDMA toxicity
Quinton, M. S., & Yamamoto, B. K. (2006) · The AAPS Journal · doi:10.1007/bf02854904 · Cited by 187
Can Drugs Be Used to Enhance the Psychotherapeutic Process?
Grinspoon, L., & Bakalar, J. B. (1986) · American Journal of Psychotherapy · doi:10.1176/appi.psychotherapy.1986.40.3.393 · Cited by 187
Prevalence and Magnitude of Perinatal Substance Exposures in California
Vega, W. A., Kolody, B., Hwang, J., & Noble, A. (1993) · New England Journal of Medicine · doi:10.1056/nejm199309163291207 · Cited by 187
Pharmacogenetics of the serotonin transporter
Lesch, K. P., & Gutknecht, L. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2005.03.012 · Cited by 186
Effects of amphetamines on mitochondrial function: role of free radicals and oxidative stress
Brown, J. M., & Yamamoto, B. K. (2003) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(03)00052-4 · Cited by 184
Cardiomyopathy Associated With the Smoking of Crystal Methamphetamine
Hong, R. (1991) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1991.03460090100040 · Cited by 183
Ecstasy: A common cause of severe acute hepatotoxicity
Andreu, V., Mas, A., Bruguera, M., Salmerón, J. M., Moreno, V., Nogué, S., & Rodés, J. (1998) · Journal of Hepatology · doi:10.1016/s0168-8278(98)80056-1 · Cited by 182
A bitter pill. Overview of ecstasy (MDMA, MDA) related fatalities
Schifano, F. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1730-5 · Cited by 181
A review of the mechanisms involved in the acute MDMA (ecstasy)-induced hyperthermic response
Green, A. R., O'Shea, E., & Colado, M. I. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.07.006 · Cited by 181
Nash, J. F., Meltzer, H. Y., & Gudelsky, G. A. (1988) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24086-1 · Cited by 179
The confounding problem of polydrug use in recreational ecstasy/MDMA users: a brief overview
Gouzoulis-Mayfrank, E., & Daumann, J. (2006) · Journal of Psychopharmacology · doi:10.1177/0269881106059939 · Cited by 179
Pharmacology of MDMA in Humans
DE LA TORRE, R., FARRÉ, M., ROSET, P. N., LÓPEZ, C. H., MAS, M., ORTUÑO, J., MENOYO, E., PIZARRO, N., SEGURA, J., & CAMÍ, J. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb05199.x · Cited by 179
Cytochrome P450 Regulation and Drug Biotransformation During Inflammation and Infection
Renton, K. (2004) · Current Drug Metabolism · doi:10.2174/1389200043335559 · Cited by 179
3,4-Methylenedioxy analogues of amphetamine: Defining the risks to humans
Hegadoren, K. M., Baker, G. B., & Bourin, M. (1999) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(98)00046-3 · Cited by 178
Amphetamines induce apoptosis and regulation of bcl‐x splice variants in neocortical neurons
Stumm, G., Schlegel, J., Schäfer, T., Würz, C., Mennel, H. D., Krieg, J. ‐., & Vedder, H. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.9.1065 · Cited by 177
Crespi, D., Mennini, T., & Gobbi, M. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701325 · Cited by 174
Colado, M. I., O'Shea, E., Granados, R., Murray, T. K., & Green, A. R. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701213 · Cited by 174
Interactions of amphetamine analogs with human liver CYP2D6
Wu, D., Otton, S. V., Inaba, T., Kalow, W., & Sellers, E. M. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)00014-2 · Cited by 173
Kish, S. J., Lerch, J., Furukawa, Y., Tong, J., McCluskey, T., Wilkins, D., Houle, S., Meyer, J., Mundo, E., Wilson, A. A., et al. (2010) · Brain · doi:10.1093/brain/awq103 · Cited by 172
Early pharmacokinetics and clinical effects of oral d-amphetamine in normal subjects
Angrist, B., Corwin, J., Bartlik, B., & Cooper, T. (1987) · Biological Psychiatry · doi:10.1016/0006-3223(87)90070-9 · Cited by 171
Schwartz, D. L., Mitchell, A. D., Lahna, D. L., Luber, H. S., Huckans, M. S., Mitchell, S. H., & Hoffman, W. F. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2010.01.056 · Cited by 171
Multiple Severe Complications From Recreational Ingestion of MDMA ('Ecstasy')
Brown, C. (1987) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1987.03400060056021 · Cited by 170
The bioavailability of intranasal and smoked methamphetamine
Harris, D. E., Boxenbaum, H., Everhart, E. T., Sequeira, G., Mendelson, J. E., & Jones, R. T. (2003) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2003.08.002 · Cited by 170
Repeated doses administration of MDMA in humans: pharmacological effects and pharmacokinetics
Farré, M., de la Torre, R., Ó Mathúna, B., Roset, P. N., Peiró, A. M., Torrens, M., Ortuño, J., Pujadas, M., & Camí, J. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1789-7 · Cited by 169
Yamamoto, B. K., & Raudensky, J. (2008) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-008-9121-7 · Cited by 167
Distribution and Pharmacokinetics of Methamphetamine in the Human Body: Clinical Implications
Volkow, N. D., Fowler, J. S., Wang, G.-J., Shumay, E., Telang, F., Thanos, P. K., & Alexoff, D. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015269 · Cited by 167
Kim, S. K., & Novak, R. F. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.07.004 · Cited by 167
Hysek, C. M., Simmler, L. D., Ineichen, M., Grouzmann, E., Hoener, M. C., Brenneisen, R., Huwyler, J., & Liechti, M. E. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.78 · Cited by 166
Vallée, M., Mayo, W., Maccari, S., Moal, M. L., & Simon, H. (1996) · Brain Research · doi:10.1016/0006-8993(95)01459-4 · Cited by 166
Scholey, A. B., Parrott, A. C., Buchanan, T., Heffernan, T. M., Ling, J., & Rodgers, J. (2004) · Addictive Behaviors · doi:10.1016/j.addbeh.2004.02.022 · Cited by 166
Parrott, A. C. (2004) · Neuropsychobiology · doi:10.1159/000080961 · Cited by 165
Bupropion Reduces Methamphetamine-Induced Subjective Effects and Cue-Induced Craving
Newton, T. F., Roache, J. D., De La Garza, R., Fong, T., Wallace, C. L., Li, S.-H., Elkashef, A., Chiang, N., & Kahn, R. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300979 · Cited by 164
Burrows, K. B., Gudelsky, G. A., & Yamamoto, B. K. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00264-8 · Cited by 164
Regulation of drug metabolism and disposition during inflammation and infection
Renton, K. W. (2005) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.1.4.629 · Cited by 163
Bowyer, J. F., & Ali, S. (2006) · Synapse · doi:10.1002/syn.20324 · Cited by 162
Nisijima, K., Yoshino, T., Yui, K., & Katoh, S. (2001) · Brain Research · doi:10.1016/s0006-8993(00)03020-1 · Cited by 161
Interaction of Amphetamines and Related Compounds at the Vesicular Monoamine Transporter
Partilla, J. S., Dempsey, A. G., Nagpal, A., Blough, B. E., Baumann, M. H., & Rothman, R. B. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.103622 · Cited by 161
Acute liver damage and ecstasy ingestion.
Ellis, A. J., Wendon, J. A., Portmann, B., & Williams, R. (1996) · Gut · doi:10.1136/gut.38.3.454 · Cited by 160
Persico, A. M., Bird, G. W. G., Gabbay, F. H., & Uhl, G. R. (1996) · Biological Psychiatry · doi:10.1016/0006-3223(95)00483-1 · Cited by 160
Comparative Metabolic Capabilities and Inhibitory Profiles of CYP2D6.1, CYP2D6.10, and CYP2D6.17
Shen, H., He, M. M., Liu, H., Wrighton, S. A., Wang, L., Guo, B., & Li, C. (2007) · Drug Metabolism and Disposition · doi:10.1124/dmd.107.015354 · Cited by 160
Helmlin, H.-J., Bracher, K., Bourquin, D., Vonlanthen, D., Brenneisen, R., & Styk, J. (1996) · Journal of Analytical Toxicology · doi:10.1093/jat/20.6.432 · Cited by 159
Hyperpyrexia and rhabdomyolysis after MDMA ("ecstasy") abuse
Screaton, G. R., Cairns, H., Sarner, M., Singer, M., Thrasher, A. J., & Cohen, S. L. (1992) · The Lancet · doi:10.1016/0140-6736(92)90834-p · Cited by 157
de la Torre, R., Farr, M., Navarro, M., Pacifici, R., Zuccaro, P., & Pichini, S. (2004) · Clinical Pharmacokinetics · doi:10.2165/00003088-200443030-00002 · Cited by 156
Progress in Monoamine Oxidase (MAO) Research in Relation to Genetic Engineering
Nagatsu, T. (2003) · NeuroToxicology · doi:10.1016/s0161-813x(03)00085-8 · Cited by 154
Rhabdomyolysis and Shock After Intravenous Amphetamine Administration
KENDRICK, W. C., HULL, A. R., & KNOCHEL, J. P. (1977) · Annals of Internal Medicine · doi:10.7326/0003-4819-86-4-381 · Cited by 154
A Bitter Pill: A Discursive Analysis of Women's Medicalized Accounts of Depression
Lafrance, M. N. (2006) · Journal of Health Psychology · doi:10.1177/1359105307071746 · Cited by 152
Uncoupling the agony from ecstasy
Mills, E., Banks, M. L., Sprague, J. E., & Finkel, T. (2003) · Nature · doi:10.1038/426403a · Cited by 151
Interactions Between Recreational Drugs and Antiretroviral Agents
Antoniou, T., & Tseng, A. L.-I. (2002) · Annals of Pharmacotherapy · doi:10.1345/aph.1a447 · Cited by 151
Thermoregulatory effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans
Freedman, R. R., Johanson, C., & Tancer, M. E. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0149-6 · Cited by 150
Dafters, R. I. (1995) · Physiology & Behavior · doi:10.1016/0031-9384(95)00136-7 · Cited by 150
Battaglia, G., Fornai, F., Busceti, C. L., Aloisi, G., Cerrito, F., Blasi, A. D., Melchiorri, D., & Nicoletti, F. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-06-02135.2002 · Cited by 148
Dopamine Transporter Gene Associated with Diminished Subjective Response to Amphetamine
Lott, D. C., Kim, S., Cook, E. H., & de Wit, H. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300637 · Cited by 147
Ramaekers, J. G., & Kuypers, K. P. C. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300894 · Cited by 146
McCann, U. D., Szabó, Z. R., Vranešić, M., Palermo, M., Mathews, W. B., Ravert, H. T., Dannals, R. F., & Ricaurte, G. A. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1218-4 · Cited by 146
Adverse Reactions with 3,4-Methylenedioxymethamphetamine (MDMA; ???Ecstasy???)
McCann, U. D., Slate, S. O., & Ricaurte, G. A. (1996) · Drug Safety · doi:10.2165/00002018-199615020-00003 · Cited by 145
Liechti, M. E., & Vollenweider, F. X. (2000) · Journal of Psychopharmacology · doi:10.1177/026988110001400313 · Cited by 144
Fatal interaction between ritonavir and MDMA
Henry, J., & Hill, I. R. (1998) · The Lancet · doi:10.1016/s0140-6736(05)79824-x · Cited by 143
Chadwick, I. S., Curry, P. D., Linsley, A., Freemont, A. J., & Doran, B. R. H. (1991) · Journal of the Royal Society of Medicine · doi:10.1177/014107689108400622 · Cited by 142
Owen, R., Sangkuhl, K., Klein, T. E., & Altman, R. B. (2009) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32832e0e97 · Cited by 141
Wu, C.-W., Ping, Y., Yen, J., Chang, C., Wang, S., Yeh, C.-L., Chi, C., & Lee, H. (2007) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2007.01.011 · Cited by 140
Kolbrich, E. A., Goodwin, R. S., Gorelick, D. A., Hayes, R. J., Stein, E. A., & Huestis, M. A. (2008) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0b013e3181684fa0 · Cited by 139
Parrott, A. C. (2006) · Journal of Psychopharmacology · doi:10.1177/0269881106063268 · Cited by 139
Fallon, J. K., Kicman, A. T., Henry, J. A., Milligan, P. J., Cowan, D., & Hutt, A. J. (1999) · Clinical Chemistry · doi:10.1093/clinchem/45.7.1058 · Cited by 139
Lester, S. J., Baggott, M. J., Welm, S., Schiller, N. B., Jones, R. T., Foster, E., & Mendelson, J. E. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-12-200012190-00012 · Cited by 138
Chao, T. C., Sinniah, R., & Pakiam, J. E. (1981) · Pathology · doi:10.3109/00313028109086837 · Cited by 136
Cervinski, M., Foster, J., & Vaughan, R. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501969200 · Cited by 136
Navarro, M., Pichini, S., Farré, M., Ortuño, J., Roset, P. N., Segura, J., & de la Torre, R. (2001) · Clinical Chemistry · doi:10.1093/clinchem/47.10.1788 · Cited by 136
Acute Physiological and Behavioral Effects of Intranasal Methamphetamine in Humans
Hart, C. L., Gunderson, E. W., Perez, A. Y., Kirkpatrick, M. G., Thurmond, A., Comer, S. D., & Foltin, R. W. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301578 · Cited by 135
Methamphetamine users show greater than normal age‐related cortical gray matter loss
Nakama, H., Chang, L., Fein, G., Shimotsu, R., Jiang, C. S., & Ernst, T. M. (2011) · Addiction · doi:10.1111/j.1360-0443.2011.03433.x · Cited by 133
Reduced cortical gray matter density in human MDMA (Ecstasy) users: a voxel-based morphometry study
Cowan, R. L., Lyoo, I. K., Sung, S. M., Ahn, K. H., Kim, M. J., Hwang, J., Haga, E., Vimal, R. L. P., Lukas, S. E., & Renshaw, P. F. (2003) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2003.07.001 · Cited by 132
Guilarte, T. R., Nihei, M. K., McGlothan, J. L., & Howard, A. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00476-7 · Cited by 132
STONE, D., Gr, H., & Gibb, J. W. (1987) · Neuropharmacology · doi:10.1016/0028-3908(87)90017-7 · Cited by 131
Cloning, expression and structure of catechol-O-methyltransferase
Lundstrom, K. H., Tenhunen, J., Tilgmann, C., Karhunen, T., Panula, P., & Ulmanen, I. (1995) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/0167-4838(95)00071-2 · Cited by 131
Ujike, H., Harano, M., Inada, T., Yamada, M., Komiyama, T., Sekine, Y., Sora, I., Iyo, M., Katsu, T., Nomura, A., et al. (2003) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500189 · Cited by 130
Methamphetamine abuse and rhabdomyolysis in the ED: A 5-year study
Richards, J. R., Johnson, E. B., Stark, R. W., & Derlet, R. W. (1999) · The American Journal of Emergency Medicine · doi:10.1016/s0735-6757(99)90159-6 · Cited by 130
Roiser, J. P., Rogers, R. D., Cook, L. J., & Sahakian, B. J. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0495-z · Cited by 130
Death in amphetamine users: causes and rates.
Kalant, H., & Kalant, O. J. (1975) · PubMed Central · Cited by 129
Zhu, J. P. Q., Xu, W., & Angulo, J. A. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.02.055 · Cited by 129
Zhang, F., & Dryhurst, G. (1994) · Journal of Medicinal Chemistry · doi:10.1021/jm00034a006 · Cited by 129
Plasma Protein Binding of Drugs in Pregnancy and in Neonates
Notarianni, L. J. (1990) · Clinical Pharmacokinetics · doi:10.2165/00003088-199018010-00002 · Cited by 127
Wappler, F. (2001) · European Journal of Anaesthesiology · doi:10.1097/00003643-200110000-00002 · Cited by 127
Serotonergic Neurotoxic Metabolites of Ecstasy Identified in Rat Brain
Jones, D. C., Duvauchelle, C. L., Ikegami, A., Olsen, C. M., Lau, S. S., de la Torre, R., & Monks, T. J. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.077628 · Cited by 126
Cocaine and methamphetamine produce different patterns of subjective and cardiovascular effects
Newton, T. F., Garza, R. D. L., Kalechstein, A. D., & Nestor, L. J. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.07.012 · Cited by 125
Methamphetamine and ethanol interactions in humans*
Mendelson, J. E., Jones, R. T., Upton, R. A., & Jacob, P. (1995) · Clinical Pharmacology & Therapeutics · doi:10.1016/0009-9236(95)90041-1 · Cited by 125
Association analysis of the DRD4 and COMT genes in methamphetamine abuse
Li, T., Chen, C. Y., Hu, X., Ball, D., Lin, S., Chen, W., Sham, P. C., Loh, E., Murray, R. M., & Collier, D. A. (2004) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30024 · Cited by 124
Florin, S. M., Kuczenski, R. T., & Segal, D. S. (1994) · Brain Research · doi:10.1016/0006-8993(94)91570-9 · Cited by 124
Quinn, D. I., Wodak, A., & Day, R. O. (1997) · Clinical Pharmacokinetics · doi:10.2165/00003088-199733050-00003 · Cited by 122
Monks, T. J., Jones, D. C., Bai, F., & Lau, S. S. (2004) · Therapeutic Drug Monitoring · doi:10.1097/00007691-200404000-00008 · Cited by 122
Amphetamine Intoxication with Coagulopathy, Hyperthermia, and Reversible Renal Failure
Ginsberg, M. D., HERTZMAN, M., & SCHMIDT-NOWARA, W. W. (1970) · Annals of Internal Medicine · doi:10.7326/0003-4819-73-1-81 · Cited by 122
TOXICITY AND CATECHOLAMINE RELEASING ACTIONS OF d- AND l-AMPHETAMINE IN ISOLATED AND AGGREGATED MICE
Moore, K. E. (1963) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)26632-0 · Cited by 121
Cited by
Khat and synthetic cathinones: a review
Valente, M. J., Guedes de Pinho, P., de Lourdes Bastos, M., Carvalho, F., & Carvalho, M. (2014) · Archives of Toxicology · doi:10.1007/s00204-013-1163-9 · Cited by 337
Self-citationComprehensive review of cardiovascular toxicity of drugs and related agents
Mladěnka, P., Applová, L., Patočka, J., Costa, V. M., Remiao, F., Pourová, J., Mladěnka, A., Karlíčková, J., Jahodář, L., Vopršalová, M., et al. (2018) · Medicinal Research Reviews · doi:10.1002/med.21476 · Cited by 310
Self-citationDesigner drugs: mechanism of action and adverse effects
Luethi, D., & Liechti, M. E. (2020) · Archives of Toxicology · doi:10.1007/s00204-020-02693-7 · Cited by 262
Mechanisms of Action and Persistent Neuroplasticity by Drugs of Abuse
Korpi, E. R., den Hollander, B., Farooq, U., Vashchinkina, E., Rajkumar, R., Nutt, D. J., Hyytiä, P., & Dawe, G. S. (2015) · Pharmacological Reviews · doi:10.1124/pr.115.010967 · Cited by 148
Ceceli, A. O., Bradberry, C. W., & Goldstein, R. Z. (2022) · Neuropsychopharmacology · doi:10.1038/s41386-021-01153-9 · Cited by 150
Metadata
- Authors
- Carvalho, M., Carmo, H., Costa, V. M., Capela, J. P., Pontes, H., Remião, F., Carvalho, F., & Bastos, M. D. L.
- Venue
- Archives of Toxicology
- Published
- 2012-03-06
- Volume
- 86
- Issue
- 8
- Pages
- 1167-1231
- ISSN
- 0340-5761 (ISSN-L)
- 1432-0738
- OpenAlex
- W1971191340
- Cited by
- 431
- References
- 496
- FWCI
- 48.00
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.